Jiangsu ChengXing Phosph-Chemicals Co., Ltd. (SHA:600078)
China · Delayed Price · Currency is CNY 11.13
-0.07 (-0.63%)
Feb 13, 2026, 3:00 PM CST
SHA:600078 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 3,452 | 3,230 | 3,032 | 4,465 | 3,055 | 3,066 |
Other Revenue | 125.67 | 125.67 | 68.99 | 72.55 | 278.87 | 70.97 |
| 3,578 | 3,356 | 3,101 | 4,538 | 3,333 | 3,137 | |
Revenue Growth (YoY) | 15.22% | 8.22% | -31.66% | 36.12% | 6.28% | -5.24% |
Cost of Revenue | 3,226 | 3,123 | 2,798 | 3,550 | 2,664 | 2,877 |
Gross Profit | 351.61 | 232.86 | 303.24 | 987.72 | 669.89 | 259.56 |
Selling, General & Admin | 207.42 | 209.86 | 196.81 | 188.84 | 135.18 | 192.34 |
Research & Development | 4.5 | 8.87 | 6.31 | 0.4 | - | - |
Other Operating Expenses | 42.84 | 42.11 | 35.59 | 53.91 | -8.69 | 84.93 |
Operating Expenses | 275.12 | 284.7 | 236.22 | 256.62 | 143.83 | 280.17 |
Operating Income | 76.48 | -51.84 | 67.02 | 731.1 | 526.06 | -20.61 |
Interest Expense | -110.46 | -119.62 | -115.26 | -126.54 | -206.72 | -189.39 |
Interest & Investment Income | 41.19 | 45.06 | 55.47 | 61.69 | 62.39 | 60.21 |
Currency Exchange Gain (Loss) | 5.87 | 5.87 | 5.47 | 17.87 | -2.75 | -8.45 |
Other Non Operating Income (Expenses) | -6.57 | -14.04 | -1.11 | 227.65 | 1,894 | -2,130 |
EBT Excluding Unusual Items | 6.52 | -134.56 | 11.58 | 911.76 | 2,273 | -2,288 |
Gain (Loss) on Sale of Assets | 31.87 | 1.39 | 5.6 | 0 | -1.52 | -2.75 |
Asset Writedown | -3.12 | -3.12 | - | - | -0.78 | -14.59 |
Legal Settlements | -26.08 | -26.08 | -0.09 | -5.1 | -68.39 | - |
Other Unusual Items | 3.51 | 6.12 | -3.43 | -32.79 | -42.54 | 11.4 |
Pretax Income | 12.7 | -156.25 | 13.67 | 873.88 | 2,160 | -2,294 |
Income Tax Expense | 31.93 | -21.49 | -16.87 | 92.99 | 25.31 | -21.5 |
Earnings From Continuing Operations | -19.24 | -134.76 | 30.54 | 780.89 | 2,135 | -2,272 |
Minority Interest in Earnings | -83.76 | -64.13 | -91.37 | -259.12 | -119.64 | -28.33 |
Net Income | -103 | -198.9 | -60.83 | 521.77 | 2,015 | -2,301 |
Net Income to Common | -103 | -198.9 | -60.83 | 521.77 | 2,015 | -2,301 |
Net Income Growth | - | - | - | -74.11% | - | - |
Shares Outstanding (Basic) | 666 | 663 | 663 | 663 | 663 | 663 |
Shares Outstanding (Diluted) | 666 | 663 | 663 | 663 | 663 | 663 |
Shares Change (YoY) | 0.92% | -0.01% | 0.01% | -0.05% | -0.01% | -1.14% |
EPS (Basic) | -0.15 | -0.30 | -0.09 | 0.79 | 3.04 | -3.47 |
EPS (Diluted) | -0.15 | -0.30 | -0.09 | 0.79 | 3.04 | -3.47 |
EPS Growth | - | - | - | -74.09% | - | - |
Free Cash Flow | 323.61 | 113.88 | 468.15 | 344.15 | 452.73 | 602.71 |
Free Cash Flow Per Share | 0.49 | 0.17 | 0.71 | 0.52 | 0.68 | 0.91 |
Dividend Per Share | - | - | 0.031 | 0.080 | - | - |
Dividend Growth | - | - | -61.25% | - | - | - |
Gross Margin | 9.83% | 6.94% | 9.78% | 21.77% | 20.10% | 8.28% |
Operating Margin | 2.14% | -1.54% | 2.16% | 16.11% | 15.78% | -0.66% |
Profit Margin | -2.88% | -5.93% | -1.96% | 11.50% | 60.46% | -73.35% |
Free Cash Flow Margin | 9.04% | 3.39% | 15.10% | 7.58% | 13.58% | 19.22% |
EBITDA | 302.89 | 190.57 | 330.77 | 992.53 | 794.82 | 257.2 |
EBITDA Margin | 8.46% | 5.68% | 10.67% | 21.87% | 23.84% | 8.20% |
D&A For EBITDA | 226.41 | 242.41 | 263.75 | 261.43 | 268.76 | 277.81 |
EBIT | 76.48 | -51.84 | 67.02 | 731.1 | 526.06 | -20.61 |
EBIT Margin | 2.14% | -1.54% | 2.16% | 16.11% | 15.78% | -0.66% |
Effective Tax Rate | 251.51% | - | - | 10.64% | 1.17% | - |
Revenue as Reported | 3,578 | 3,356 | 3,101 | 4,538 | 3,333 | 3,137 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.